Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Purchased by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC raised its position in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD - Free Report) by 10.7% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 152,567 shares of the consumer goods maker's stock after purchasing an additional 14,781 shares during the quarter. Thompson Siegel & Walmsley LLC's holdings in Anheuser-Busch InBev SA/NV were worth $10,114,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Ashton Thomas Securities LLC bought a new position in shares of Anheuser-Busch InBev SA/NV in the third quarter worth about $26,000. GPS Wealth Strategies Group LLC raised its holdings in Anheuser-Busch InBev SA/NV by 50.7% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 550 shares of the consumer goods maker's stock valued at $32,000 after buying an additional 185 shares during the period. Blue Trust Inc. lifted its position in Anheuser-Busch InBev SA/NV by 225.0% in the second quarter. Blue Trust Inc. now owns 546 shares of the consumer goods maker's stock worth $33,000 after buying an additional 378 shares during the last quarter. Addison Advisors LLC boosted its stake in Anheuser-Busch InBev SA/NV by 39.7% during the second quarter. Addison Advisors LLC now owns 591 shares of the consumer goods maker's stock worth $34,000 after buying an additional 168 shares during the period. Finally, Hantz Financial Services Inc. bought a new position in Anheuser-Busch InBev SA/NV during the second quarter valued at $35,000. Hedge funds and other institutional investors own 5.53% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on BUD. Morgan Stanley increased their price target on Anheuser-Busch InBev SA/NV from $68.50 to $73.00 and gave the stock an "overweight" rating in a report on Tuesday, September 10th. Evercore ISI upgraded shares of Anheuser-Busch InBev SA/NV to a "strong-buy" rating in a report on Monday, September 30th. TD Cowen lowered shares of Anheuser-Busch InBev SA/NV from a "buy" rating to a "hold" rating and lifted their price objective for the company from $68.00 to $88.00 in a report on Tuesday, October 8th. Barclays upgraded shares of Anheuser-Busch InBev SA/NV to a "strong-buy" rating in a research note on Wednesday, October 9th. Finally, Citigroup raised shares of Anheuser-Busch InBev SA/NV from a "neutral" rating to a "buy" rating in a research note on Tuesday, October 1st. Three analysts have rated the stock with a hold rating, five have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, Anheuser-Busch InBev SA/NV presently has an average rating of "Moderate Buy" and a consensus price target of $79.00.

Anheuser-Busch InBev SA/NV Trading Up 0.1 %

Anheuser-Busch InBev SA/NV stock traded up $0.03 during mid-day trading on Friday, hitting $54.72. The company's stock had a trading volume of 1,919,828 shares, compared to its average volume of 1,643,947. The stock's fifty day moving average is $62.09 and its two-hundred day moving average is $61.82. The company has a current ratio of 0.69, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $98.34 billion, a PE ratio of 16.89, a price-to-earnings-growth ratio of 1.79 and a beta of 1.12. Anheuser-Busch InBev SA/NV has a 1 year low of $54.51 and a 1 year high of $67.49.

Anheuser-Busch InBev SA/NV Company Profile

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.